|4Dec 16, 4:31 PM ET

Corrigan Catherine 4

4 · EXPONENT INC · Filed Dec 16, 2025

Insider Transaction Report

Form 4
Period: 2025-12-15
Corrigan Catherine
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-15$25.41/sh+3,225$81,93187,359 total
  • Sale

    Common Stock

    2025-12-15$70.74/sh3,225$228,13284,134 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-12-153,22516,128 total
    Exercise: $25.41Exp: 2026-07-29Common Stock (3,225 underlying)
Footnotes (2)
  • [F1]The stock option becomes exercisable in four equal annual installments.
  • [F2]Not applicable.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT